GEA Group AG, DE0006602006

GEA stock holds near a 52-week low as 2025 sales rose

Published on 08/19/2026 at 08:23 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

GEA stock is steady after the latest market snapshot, with 2025 revenue at EUR 5.5 billion and 2025 EPS at EUR 2.18 as investors weigh margin pressure and the next earnings date.

Makrofoto einer polierten Edelstahloberfläche mit Wassertropfen und Schweißnähten
Makroaufnahme einer Edelstahloberfläche veranschaulicht Präzisionstechnik von GEA Group AG, ISIN DE0006602006, im Anlagenbau, Illustration mit AI erstellt.

GEA stock holds near a 52-week low after the latest market snapshot put the shares at EUR 46.72 on August 18, 2026, with a 52-week range of EUR 27.56 to EUR 46.72 and a market cap of EUR 959.52 million.

Latest snapshot

The same market view shows revenue of EUR 2.32 billion on a trailing-twelve-month basis, net income of minus EUR 320.32 million and EPS of minus EUR 9.27. Those figures keep the focus on profitability rather than sales alone, especially after the stock's 1-year return of minus 37.49% and year-to-date gain of 1.45%.

Estimated earnings are listed for August 27, 2026, which gives the next reporting date an immediate calendar anchor for investors watching the next update.

Fundamentals in context

Historically, the company reported EUR 2.320885 billion in fiscal 2025 revenue, up 16.6% from fiscal 2024, while diluted EPS swung to minus EUR 9.27 from EUR 2.38 a year earlier. That contrast is the key comparison: sales growth remained positive, but earnings weakened sharply.

Cash stood at EUR 176.21 million against total debt of EUR 1.60 billion in the latest financial view, and free cash flow was minus EUR 98.80 million on a trailing basis. For investors, the balance sheet and cash generation remain just as relevant as the revenue line.

Product mix

GEA's portfolio spans plastics and devices, primary packaging glass and advanced technologies, including inhalers, insulin pen systems, prefillable syringes, bottles, vials and micro pumps. That mix matters because drug delivery and packaging demand can move differently across pharma, biotech, diagnostics and medical technology customers.

Stock view

GEA shares trade in euros on the home market, and the current pricing picture is still shaped by the gap between sales growth and earnings pressure. The combination of EUR 959.52 million market value, EUR 2.32 billion in revenue and minus EUR 320.32 million in net income is what stands out most on August 19, 2026.

More on GEA stock

Company: GEA Group AG

ISIN: DE0006602006

Ticker: G1A

Exchange: Xetra

Sector / Industry: Industrials / Machinery

Index membership: MDAX

Price (as of August 18, 2026): EUR 46.72

Market cap: EUR 959.52 million

Next earnings date: August 27, 2026

Disclaimer...

en | DE0006602006 | GEA GROUP AG | boerse | 69967925 | bgmi